IONIS PHARMACEUTICALS INC Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q2 2015 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Ionis Pharmaceuticals Inc quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q2 2015 to Q2 2025.
- Ionis Pharmaceuticals Inc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending June 30, 2025 was $452M, a 101% increase year-over-year.
- Ionis Pharmaceuticals Inc Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending June 30, 2025 was $944M, a 16.1% increase year-over-year.
- Ionis Pharmaceuticals Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $705M, a 10.5% decline from 2023.
- Ionis Pharmaceuticals Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $788M, a 34.1% increase from 2022.
- Ionis Pharmaceuticals Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $587M, a 27.5% decline from 2021.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)